CRIPTO and glioblastoma: Finally, our data suggest the involvement of the EV-associated CRIPTO protein in the reduction of U87 GBM cell migration induced by NTERA2 lEVs, paving the way to the possible use of EV-associated CRIPTO as a key player in GBM therapy.